ClinConnect ClinConnect Logo
Search / Trial NCT06838793

ITPB 1 vs 3 in VATS

Launched by CHINESE UNIVERSITY OF HONG KONG · Feb 17, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Intertransverse Process Block Video Assisted Thoracscopic Surgery Quality Of Recovery

ClinConnect Summary

This clinical trial is looking at how well patients recover after a specific type of lung surgery called video-assisted thoracoscopic surgery (VATS). The researchers want to compare two different techniques for pain relief during the surgery: one that targets a single area of the spine and another that targets three areas. They will measure recovery quality using a simple survey called the QoR15, which helps understand how patients feel 24 hours after the surgery.

To take part in the study, participants need to be between 18 and 80 years old and scheduled for lung surgery due to lung cancer. People who are generally healthy (classified as ASA I-III) can join, but those who refuse to participate, have infections where the injection would go, or have certain health issues won’t be eligible. If you join this trial, you can expect to be closely monitored after your surgery to see how well each pain relief method works. Overall, this study aims to improve recovery experiences for future patients undergoing similar procedures.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • ASA I-III patients
  • 18 to 80 years of age
  • Patients with primary carcinoma lung scheduled for resection under VATS procedure
  • Exclusion Criteria:
  • Patient refusal
  • Local skin infection at the area of injection
  • Coagulopathy
  • History of allergy to local anaesthetics

About Chinese University Of Hong Kong

The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.

Locations

New Territories, , Hong Kong

Patients applied

0 patients applied

Trial Officials

Manoj K Karmakar, MD, FRCA

Principal Investigator

Chinese University of Hong Kong

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported